277 related articles for article (PubMed ID: 35938824)
1. Prediction of Th1 and Cytotoxic T Lymphocyte Epitopes of
Gong W; Liang Y; Wang J; Liu Y; Xue Y; Mi J; Li P; Wang X; Wang L; Wu X
Microbiol Spectr; 2022 Aug; 10(4):e0143822. PubMed ID: 35938824
[TBL] [Abstract][Full Text] [Related]
2. Mycobacterium tuberculosis latency-associated antigen Rv1733c SLP improves the accuracy of differential diagnosis of active tuberculosis and latent tuberculosis infection.
Zhang L; Ma H; Wan S; Zhang Y; Gao M; Liu X
Chin Med J (Engl); 2022 Jan; 135(1):63-69. PubMed ID: 34802023
[TBL] [Abstract][Full Text] [Related]
3. Combination of Blood Routine Examination and T-SPOT.TB Assay for Distinguishing Between Active Tuberculosis and Latent Tuberculosis Infection.
Luo Y; Tang G; Yuan X; Lin Q; Mao L; Song H; Xue Y; Wu S; Ouyang R; Hou H; Wang F; Sun Z
Front Cell Infect Microbiol; 2021; 11():575650. PubMed ID: 34277462
[TBL] [Abstract][Full Text] [Related]
4. Activation Phenotype of
Luo Y; Xue Y; Mao L; Lin Q; Tang G; Song H; Liu W; Tong S; Hou H; Huang M; Ouyang R; Wang F; Sun Z
Front Immunol; 2021; 12():721013. PubMed ID: 34512645
[TBL] [Abstract][Full Text] [Related]
5. A combination of iron metabolism indexes and tuberculosis-specific antigen/phytohemagglutinin ratio for distinguishing active tuberculosis from latent tuberculosis infection.
Luo Y; Xue Y; Lin Q; Tang G; Yuan X; Mao L; Song H; Wang F; Sun Z
Int J Infect Dis; 2020 Aug; 97():190-196. PubMed ID: 32497795
[TBL] [Abstract][Full Text] [Related]
6. Lymphocyte Non-Specific Function Detection Facilitating the Stratification of
Luo Y; Xue Y; Cai Y; Lin Q; Tang G; Song H; Liu W; Mao L; Yuan X; Zhou Y; Liu W; Wu S; Sun Z; Wang F
Front Immunol; 2021; 12():641378. PubMed ID: 33953714
[TBL] [Abstract][Full Text] [Related]
7. Combination of HLA-DR on
Luo Y; Xue Y; Tang G; Lin Q; Song H; Liu W; Yin B; Huang J; Wei W; Mao L; Wang F; Sun Z
Front Immunol; 2021; 12():761209. PubMed ID: 34858413
[TBL] [Abstract][Full Text] [Related]
8. A novel chemokine biomarker to distinguish active tuberculosis from latent tuberculosis: a cohort study.
Li H; Ren W; Liang Q; Zhang X; Li Q; Shang Y; Ma L; Li S; Pang Y
QJM; 2023 Dec; 116(12):1002-1009. PubMed ID: 37740371
[TBL] [Abstract][Full Text] [Related]
9. QuantiFERON-TB Gold Plus combined with HBHA-Induced IFN-γ release assay improves the accuracy of identifying tuberculosis disease status.
Tang J; Huang Y; Jiang S; Huang F; Ma T; Qi Y; Ma Y
Tuberculosis (Edinb); 2020 Sep; 124():101966. PubMed ID: 32866942
[TBL] [Abstract][Full Text] [Related]
10. Combination of mean spot sizes of ESAT-6 spot-forming cells and modified tuberculosis-specific antigen/phytohemagglutinin ratio of T-SPOT.TB assay in distinguishing between active tuberculosis and latent tuberculosis infection.
Luo Y; Tang G; Lin Q; Mao L; Xue Y; Yuan X; Ouyang R; Wu S; Yu J; Zhou Y; Liu W; Hou H; Wang F; Sun Z
J Infect; 2020 Jul; 81(1):81-89. PubMed ID: 32360883
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic Potential of the Serological Response to Synthetic Peptides from
Araujo Z; de Waard JH; Camargo M; Lopez-Ramos JE; de Larrea CF; Vanegas M; Patarroyo MA
Int J Pept Res Ther; 2022; 28(3):98. PubMed ID: 35528735
[TBL] [Abstract][Full Text] [Related]
12. [The ratio of tuberculosis-specific antigen to phytohemagglutinin in T-SPOT assay in the diagnosis of active tuberculosis].
Wang T; Tan YJ; Wu SJ; Huang M; Yin BT; Huang J; Wei N; Wei W; Wang F
Zhonghua Jie He He Hu Xi Za Zhi; 2019 Apr; 42(4):262-267. PubMed ID: 30955283
[No Abstract] [Full Text] [Related]
13. Novel serological biomarker panel using protein microarray can distinguish active TB from latent TB infection.
Li J; Wang Y; Yan L; Zhang C; He Y; Zou J; Zhou Y; Zhong C; Zhang X
Microbes Infect; 2022; 24(8):105002. PubMed ID: 35598729
[TBL] [Abstract][Full Text] [Related]
14. Combination of prealbumin and tuberculosis-specific antigen/phytohemagglutinin ratio for discriminating active tuberculosis from latent tuberculosis infection.
Luo Y; Xue Y; Yuan X; Lin Q; Tang G; Mao L; Song H; Wang F; Sun Z
Int J Clin Pract; 2021 Apr; 75(4):e13831. PubMed ID: 33175465
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of Mycobacterium tuberculosis-specific antibody responses for the discrimination of active and latent tuberculosis infection.
Wang S; Wu J; Chen J; Gao Y; Zhang S; Zhou Z; Huang H; Shao L; Jin J; Zhang Y; Zhang W
Int J Infect Dis; 2018 May; 70():1-9. PubMed ID: 29410147
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic performance of plasma cytokine biosignature combination and MCP-1 as individual biomarkers for differentiating stages Mycobacterium tuberculosis infection.
Luo J; Zhang M; Yan B; Li F; Guan S; Chang K; Jiang W; Xu H; Yuan T; Chen M; Deng S
J Infect; 2019 Apr; 78(4):281-291. PubMed ID: 30528869
[TBL] [Abstract][Full Text] [Related]
17. Potential Role for Mycobacterium tuberculosis Specific IL-2 and IFN-γ Responses in Discriminating between Latent Infection and Active Disease after Long-Term Stimulation.
Sun Q; Wei W; Sha W
PLoS One; 2016; 11(12):e0166501. PubMed ID: 28033330
[TBL] [Abstract][Full Text] [Related]
18. Heme oxygenase-1 and neopterin plasma/serum levels and their role in diagnosing active and latent TB among HIV/TB co-infected patients: a cross sectional study.
Uwimaana E; Bagaya BS; Castelnuovo B; Kateete DP; Godwin A; Kiwanuka N; Whalen CC; Joloba ML
BMC Infect Dis; 2021 Jul; 21(1):711. PubMed ID: 34315412
[TBL] [Abstract][Full Text] [Related]
19. Utility of interferon gamma/tumor necrosis factor alpha FluoroSpot assay in differentiation between active tuberculosis and latent tuberculosis infection: a pilot study.
Zhang L; Wan S; Zhou Z; Zhang Y; Liu X
BMC Infect Dis; 2021 Jul; 21(1):651. PubMed ID: 34225667
[TBL] [Abstract][Full Text] [Related]
20.
Cheng P; Wang L; Gong W
Front Microbiol; 2022; 13():947852. PubMed ID: 35836423
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
